We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Remdesivir Trials in China Suspended Due to Recruitment Issues
The item has been added to your shopping cart.
Remdesivir Trials in China Suspended Due to Recruitment Issues
As the desperate search for a COVID-19 treatment continues, two phase 3 trials in China of Gilead’s remdesivir as a treatment have been suspended due to the lack of eligible patients. Meanwhile, multiple trials of the drug in the U.S. and Europe are going forward.